Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Change in Account Payables (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Change in Account Payables readings, the most recent being -$9.4 million for Q4 2025.

  • On a quarterly basis, Change in Account Payables fell 15.38% to -$9.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$3.8 million, a 189.11% decrease, with the full-year FY2025 number at -$3.8 million, down 189.11% from a year prior.
  • Change in Account Payables hit -$9.4 million in Q4 2025 for Treace Medical Concepts, down from -$3.9 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $9.3 million in Q1 2024 to a low of -$9.4 million in Q4 2025.
  • Median Change in Account Payables over the past 5 years was $555000.0 (2023), compared with a mean of $223050.0.
  • Biggest five-year swings in Change in Account Payables: skyrocketed 1098.33% in 2022 and later crashed 769.44% in 2025.
  • Treace Medical Concepts' Change in Account Payables stood at $1.6 million in 2021, then plummeted by 51.24% to $787000.0 in 2022, then soared by 300.89% to $3.2 million in 2023, then plummeted by 357.59% to -$8.1 million in 2024, then decreased by 15.38% to -$9.4 million in 2025.
  • The last three reported values for Change in Account Payables were -$9.4 million (Q4 2025), -$3.9 million (Q3 2025), and $6.7 million (Q2 2025) per Business Quant data.